174 related articles for article (PubMed ID: 17121494)
1. Update on treatment of arthritis in children: new treatments, new goals.
Lovell DJ
Bull NYU Hosp Jt Dis; 2006; 64(1-2):72-6. PubMed ID: 17121494
[TBL] [Abstract][Full Text] [Related]
2. TNFalpha-blocking agents or conventional immunosuppressive drugs in the therapy of children with uveitis? - an evidence based approach.
Winterhalter S; Niehues T
Klin Padiatr; 2008; 220(6):342-7. PubMed ID: 18949668
[TBL] [Abstract][Full Text] [Related]
3. Update on biologics in juvenile idiopathic arthritis.
Ilowite NT
Curr Opin Rheumatol; 2008 Sep; 20(5):613-8. PubMed ID: 18698187
[TBL] [Abstract][Full Text] [Related]
4. Juvenile idiopathic arthritis--current and future therapies.
Kahn P
Bull NYU Hosp Jt Dis; 2009; 67(3):291-302. PubMed ID: 19852753
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register.
Prince FH; Twilt M; ten Cate R; van Rossum MA; Armbrust W; Hoppenreijs EP; van Santen-Hoeufft M; Koopman-Keemink Y; Wulffraat NM; van Suijlekom-Smit LW
Ann Rheum Dis; 2009 May; 68(5):635-41. PubMed ID: 18413443
[TBL] [Abstract][Full Text] [Related]
6. Focus on adverse events of tumour necrosis factor alpha blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients.
Gerloni V; Pontikaki I; Gattinara M; Fantini F
Ann Rheum Dis; 2008 Aug; 67(8):1145-52. PubMed ID: 17981916
[TBL] [Abstract][Full Text] [Related]
7. Juvenile idiopathic arthritis - an update on pharmacotherapy.
Kahn P
Bull NYU Hosp Jt Dis; 2011; 69(3):264-76. PubMed ID: 22035441
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate improves the health-related quality of life of children with juvenile idiopathic arthritis.
Céspedes-Cruz A; Gutiérrez-Suárez R; Pistorio A; Ravelli A; Loy A; Murray KJ; Gerloni V; Wulffraat N; Oliveira S; Walsh J; Penades IC; Alpigiani MG; Lahdenne P; Saad-Magalhães C; Cortis E; Lepore L; Kimura Y; Wouters C; Martini A; Ruperto N;
Ann Rheum Dis; 2008 Mar; 67(3):309-14. PubMed ID: 17875547
[TBL] [Abstract][Full Text] [Related]
9. [Juvenile idiopathic arthritis].
Herlin T
Ugeskr Laeger; 2002 Aug; 164(34):3941-6. PubMed ID: 12212473
[TBL] [Abstract][Full Text] [Related]
10. The magnitude of early response to methotrexate therapy predicts long-term outcome of patients with juvenile idiopathic arthritis.
Bartoli M; Tarò M; Magni-Manzoni S; Pistorio A; Traverso F; Viola S; Magnani A; Gasparini C; Martini A; Ravelli A
Ann Rheum Dis; 2008 Mar; 67(3):370-4. PubMed ID: 17660217
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of once weekly etanercept 0.8 mg/kg in a multicentre 12 week trial in active polyarticular course juvenile idiopathic arthritis.
Horneff G; Ebert A; Fitter S; Minden K; Foeldvari I; Kümmerle-Deschner J; Thon A; Girschick HJ; Weller F; Huppertz HI
Rheumatology (Oxford); 2009 Aug; 48(8):916-9. PubMed ID: 19483091
[TBL] [Abstract][Full Text] [Related]
12. New advances in the management of juvenile idiopathic arthritis--1: non-biological therapy.
Beresford MW; Baildam EM
Arch Dis Child Educ Pract Ed; 2009 Oct; 94(5):144-50. PubMed ID: 19770494
[TBL] [Abstract][Full Text] [Related]
13. [Anti-TNFalpha treatment of juvenile uveitis].
Fledelius HC; Nielsen SM; Nissen KR; Pedersen FK; Zak MS
Ugeskr Laeger; 2007 Apr; 169(14):1309-12. PubMed ID: 17437693
[TBL] [Abstract][Full Text] [Related]
14. Visual outcomes in children with juvenile idiopathic arthritis-associated uveitis.
Kump LI; Castañeda RA; Androudi SN; Reed GF; Foster CS
Ophthalmology; 2006 Oct; 113(10):1874-7. PubMed ID: 16884776
[TBL] [Abstract][Full Text] [Related]
15. Etanercept and uveitis in patients with juvenile idiopathic arthritis.
Schmeling H; Horneff G
Rheumatology (Oxford); 2005 Aug; 44(8):1008-11. PubMed ID: 15855187
[TBL] [Abstract][Full Text] [Related]
16. [EBM analysis: classic DMARDs (disease-modifying antirheumatic drugs) and immunosuppressants in arthritis and uveitis].
Niehues T; Winterhalter S; Zierhut M; Michels H; Becker MD; Heiligenhaus A
Klin Monbl Augenheilkd; 2007 Jun; 224(6):520-5. PubMed ID: 17594624
[TBL] [Abstract][Full Text] [Related]
17. [Medical treatment of juvenile idiopathic arthritis].
Kröger L; Vähäsalo P; Tynjälä P; Aalto K; Säilä H; Malin M; Putto-Laurila A; Lahdenne P
Duodecim; 2012; 128(5):477-86. PubMed ID: 22486063
[TBL] [Abstract][Full Text] [Related]
18. Drug survival of the first and second course of anti-tumour necrosis factor agents in juvenile idiopathic arthritis.
Tynjälä P; Vähäsalo P; Honkanen V; Lahdenne P
Ann Rheum Dis; 2009 Apr; 68(4):552-7. PubMed ID: 18467515
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term followup study.
Saurenmann RK; Levin AV; Feldman BM; Rose JB; Laxer RM; Schneider R; Silverman ED
Arthritis Rheum; 2007 Feb; 56(2):647-57. PubMed ID: 17265500
[TBL] [Abstract][Full Text] [Related]
20. Update on biologicals for treatment of juvenile idiopathic arthritis.
Horneff G
Expert Opin Biol Ther; 2013 Mar; 13(3):361-76. PubMed ID: 23289865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
